AstraZeneca rejects new Pfizer bid

AstraZeneca has rejected a final £69bn takeover offer from US drugs giant Pfizer, saying it undervalued the company.
The UK-based pharmaceuticals firm spurned the latest advance from the Viagra maker after it upped the price it was prepared to pay over the weekend.